AMGN compared with LIMN: revenue, margins and what each company keeps, and the suppliers and customers both name

AMGNAmgen Inc

Mkt capRevenueRevenue

LIMNLiminatus Pharma, Inc.

Mkt capRevenueRevenue

Compare

AMGNAmgen Inc

LIMNLiminatus Pharma, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

AMGNAmgen Inc

478.34· pre 479.81· delayed

Mkt cap$258.8BRevenue$10.4BQ3 FY26Revenue$36.8BFY25

LIMNLiminatus Pharma, Inc.

2.79· pre 2.93· delayed

Pre-marketNov 5 '26delayed

Mkt cap$2.7MRevenue—Revenue—

Compare

Pre-marketNov 5 '26delayed

AMGNAmgen Inc

LIMNLiminatus Pharma, Inc.

478.34pre 479.81delayed

Price

2.79pre 2.93delayed

$258.8B

Mkt cap

$2.7M

Q3 FY26$10.4B

Revenue

—

FY25$36.8B

Revenue

—

AMGN478.34vsLIMN2.79Pre-marketNov 5 '26delayed

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

LIMN: latest quarter not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only AMGN 12

PODDInsuletsupplier

CYTKCytokineticssupplier

ARWRArrowhead Pharmaceuticalssupplier

LGNDLigand Pharmaceuticalssupplier

8 more · AMGN chain ›

Shared 0

No disclosed counterparties: LIMN.

Only LIMN 0

None

Role chip = supplier or customerSource: SEC EDGAR

Price

rebased to 0%

AMGN, solidLIMN, dashed